Synthesis of Coumarin‐Thiazolidine‐2,4‐dione‐Pyrazole Hybrids as Epidermal Growth Factor Receptor (EGFR)‐Targeted Agents
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis of Coumarin‐Thiazolidine‐2,4‐dione‐Pyrazole Hybrids as Epidermal Growth Factor Receptor (EGFR)‐Targeted Agents
Authors
Keywords
-
Journal
ChemistrySelect
Volume 7, Issue 17, Pages -
Publisher
Wiley
Online
2022-05-03
DOI
10.1002/slct.202200270
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis and biological evaluation of new coumarin derivatives as cytotoxic agents
- (2021) Fatma A. Ragab et al. ARCHIV DER PHARMAZIE
- One-pot synthesis of some new regioselective 4β-pyrazolepodophyllotoxins as DNA topoisomerase-II targeting anticancer agents
- (2021) Rajkumar Nagavath et al. JOURNAL OF MOLECULAR STRUCTURE
- Design, synthesis, biological activity evaluation of 3-(4-phenyl-1H-imidazol-2-yl)-1H-pyrazole derivatives as potent JAK 2/3 and aurora A/B kinases multi-targeted inhibitors
- (2020) You-Guang Zheng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A Review on Anti-Tumor Mechanisms of Coumarins
- (2020) Yi Wu et al. Frontiers in Oncology
- Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones
- (2019) Perihan A. Elzahhar et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies
- (2019) Belma Zengin Kurt et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line
- (2019) Fatima Ezzahra Bennani et al. BIOORGANIC CHEMISTRY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A new facile way for the preparation of 3-formylcoumarins
- (2017) Andrei Y. Bochkov et al. HETEROCYCLIC COMMUNICATIONS
- GSK1059615 kills head and neck squamous cell carcinoma cells possibly via activating mitochondrial programmed necrosis pathway
- (2017) Jing Xie et al. Oncotarget
- Design, synthesis and biological evaluation of pyrazolyl-nitroimidazole derivatives as potential EGFR/HER-2 kinase inhibitors
- (2016) Xiang-Xiang Tao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Coumarins as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies
- (2015) Anuradha Thakur et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Thiazolidine-2,4-diones as multi-targeted scaffold in medicinal chemistry: Potential anticancer agents
- (2014) Vivek Asati et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia
- (2013) E. K. Keeton et al. BLOOD
- The ErbB/HER family of protein-tyrosine kinases and cancer
- (2013) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain
- (2012) Jin H. Park et al. BIOCHEMICAL JOURNAL
- Epigenetic Modulation of the Biophysical Properties of Drug-Resistant Cell Lipids to Restore Drug Transport and Endocytic Functions
- (2012) Sivakumar Vijayaraghavalu et al. MOLECULAR PHARMACEUTICS
- Membrane-active host defense peptides – Challenges and perspectives for the development of novel anticancer drugs
- (2011) Sabrina Riedl et al. CHEMISTRY AND PHYSICS OF LIPIDS
- 3,5-Disubstituted-thiazolidine-2,4-dione analogs as anticancer agents: Design, synthesis and biological characterization
- (2011) Kai Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Suppression of NF-κB and GSK-3β is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone
- (2010) Jung Ok Ban et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Privileged scaffolds for library design and drug discovery
- (2010) Matthew E Welsch et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Natural Product-Inspired Synthesis of Thiazolidine and Thiazolidinone Compounds and their Anticancer Activities
- (2010) Qiu Zhang et al. CURRENT PHARMACEUTICAL DESIGN
- A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma
- (2009) Y.-W. Lin et al. BLOOD
- Promise and challenges in drug discovery and development of hybrid anticancer drugs
- (2009) Lalji K Gediya et al. Expert Opinion on Drug Discovery
- Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus
- (2009) Francine Walker et al. HUMAN PATHOLOGY
- Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells
- (2009) Z. Beharry et al. MOLECULAR CANCER THERAPEUTICS
- Synthesis and in vitro antiproliferative activity against human cancer cell lines of novel 5-(4-methyl-benzylidene)-thiazolidine-2,4-diones
- (2008) S. Chandrappa et al. INVESTIGATIONAL NEW DRUGS
- Amphiregulin: Role in Mammary Gland Development and Breast Cancer
- (2008) Jean McBryan et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- One-pot three-component synthesis of pyrazoles through a tandem coupling-cyclocondensation sequence
- (2008) Hai-Ling Liu et al. TETRAHEDRON LETTERS
- Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors
- (2007) Richard Ducray et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search